Asymmetry Capital Management has invested in 3 companies and its latest investment was DICE on Aug 23, 2021
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
DICE is a California-based biopharmaceutical company that researches and develops novel oral therapeutics for the treatment of chronic autoimmune and inflammatory diseases.
$60M
Aug 23, 2021
-
DICE is a California-based biopharmaceutical company that researches and develops novel oral therapeutics for the treatment of chronic autoimmune and inflammatory diseases.
$80M
Dec 17, 2020
-
Galecto is a biotechnology firm that develops novel small molecule therapeutics for the treatment of fibrosis and cancer.
$64M
Sep 24, 2020
-
Frequently Asked Questions about Asymmetry Capital Management
What is Asymmetry Capital Management investing in?
Asymmetry Capital Management has invested in 3 companies including DICE, DICE and Galecto
What company did Asymmetry Capital Management invest in?
Asymmetry Capital Management invested in a total 3 companies including DICE, DICE and Galecto
What are the top 3 investments by Asymmetry Capital Management?
The top companies in which Asymmetry Capital Management invested are DICE, DICE and Galecto
